Physician Assistant in Lame Deer, MT Accepting Medicare
4 Physician Assistant nurses found. Showing 1 - 4
 Kayla Sue Mckinney, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 100 Cheyenne Ave, Lame Deer, MT 59043 Phone: 406-740-1407 |
 Luke James Altenhofen, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 100 Cheyenne Ave, Lame Deer, MT 59043 Phone: 406-477-4414 |
Ms. Tara Lynn Salley, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 100 Cheyenne Ave, Lame Deer, MT 59043 Phone: 406-477-4484 Fax: 406-477-3153 |
Mr. Harold Jeanotte, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 100 Avenue Cheyenne, Box 70, Lame Deer, MT 59043 Phone: 406-477-4400 |
News Archive
Alarm over death in clinical trial for arthritis therapy
The death of a woman taking part in a clinical trial for an arthritis therapy has set alarm bells ringing in the United States.
Delta Dental launches community grant program to promote oral health
Since 1965 when the Tennessee General Assembly passed legislation enabling its creation, Delta Dental of Tennessee has been committed to advancing and promoting the improvement of oral health in Tennessee.
State roundup: Ariz. long-term care plan advances; N.H. moves to repeal 'certificate-of-need'; Minn. ALEC legislation
The Senate Appropriations Committee unanimously passed a bill Tuesday that would make long-term health care more affordable for middle-class families. Rep. Steve Farley, D-Tucson, sponsored House Bill 2713, which would allow Arizonans to set aside money in a tax-deductible savings account to pay for long-term health-care expenses. It would also create tax deductions for long-term health insurance premiums.
SARS-CoV-2 test in 20 minutes with FISH
A collaboration from the University of Oxford and the University of Warwick has led to research into a novel method of viral detection through rapid fluorescence in situ hybridization (FISH) in order to effectively detect the SARS-CoV-2 virus within 20 minutes.
Biogen Idec, Swedish Orphan Biovitrum announce advancement of rFVIIIFc into registrational study
Biogen Idec and Swedish Orphan Biovitrum today announced that they plan to advance the companies' long-lasting, fully-recombinant factor VIII Fc fusion protein (rFVIIIFc) into a registrational clinical trial in people with hemophilia A. The decision to advance the program is based on promising data from a Phase 1/2a open-label, cross-over, multi-center, dose-escalation study that evaluated the safety and pharmacokinetics of an intravenous injection of rFVIIIFc in 16 previously-treated patients with severe hemophilia A.
› Verified 7 days ago